PL359931A1 - Phosphate transport inhibitors - Google Patents

Phosphate transport inhibitors

Info

Publication number
PL359931A1
PL359931A1 PL35993101A PL35993101A PL359931A1 PL 359931 A1 PL359931 A1 PL 359931A1 PL 35993101 A PL35993101 A PL 35993101A PL 35993101 A PL35993101 A PL 35993101A PL 359931 A1 PL359931 A1 PL 359931A1
Authority
PL
Poland
Prior art keywords
transport inhibitors
phosphate transport
phosphate
inhibitors
transport
Prior art date
Application number
PL35993101A
Other languages
English (en)
Polish (pl)
Inventor
Joseph Weinstock
Gerald Girard
Dimitri Gaitanopoulos
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of PL359931A1 publication Critical patent/PL359931A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
PL35993101A 2000-05-12 2001-05-11 Phosphate transport inhibitors PL359931A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20399500P 2000-05-12 2000-05-12
PCT/US2001/015324 WO2001087294A1 (en) 2000-05-12 2001-05-11 Phosphate transport inhibitors

Publications (1)

Publication Number Publication Date
PL359931A1 true PL359931A1 (en) 2004-09-06

Family

ID=22756167

Family Applications (1)

Application Number Title Priority Date Filing Date
PL35993101A PL359931A1 (en) 2000-05-12 2001-05-11 Phosphate transport inhibitors

Country Status (14)

Country Link
JP (1) JP2003533477A (cs)
KR (1) KR20020093983A (cs)
CN (1) CN1429108A (cs)
AU (1) AU2001261471A1 (cs)
BR (1) BR0110034A (cs)
CA (1) CA2408667A1 (cs)
CZ (1) CZ20023701A3 (cs)
HU (1) HUP0302234A2 (cs)
IL (1) IL152587A0 (cs)
MX (1) MXPA02011160A (cs)
NO (1) NO20025399D0 (cs)
PL (1) PL359931A1 (cs)
WO (1) WO2001087294A1 (cs)
ZA (1) ZA200209106B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2378179A (en) * 2001-08-03 2003-02-05 Pantherix Ltd Aromatic sulfonamides and their use in treating bacterial diseases
US7119120B2 (en) * 2001-12-26 2006-10-10 Genzyme Corporation Phosphate transport inhibitors
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
MX2011007024A (es) 2008-12-31 2011-09-27 Aedelyx Inc Compuestos y metodos para inhibir el antiporte mediado por intercambiador de iones de sodio/iones de hidrogeno (nhe) en el tratamiento de trastornos asociados con retencion de fluido o sobrecarga de sal y trastornos del tracto gastrointestinal.
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
MX366293B (es) 2012-08-21 2019-07-04 Ardelyx Inc Compuestos y metodos para inhibir al antipuerto mediado por nhe en el tratamiento de trastornos asociados con la retencion de fluidos o la sobrecarga de sal y trastornos del tracto gastrointestinal.
CN103183623A (zh) * 2013-03-12 2013-07-03 中国医学科学院医药生物技术研究所 一组苯磺酰胺基苯甲酰胺类衍生物及制备和应用
KR20250026881A (ko) 2013-04-12 2025-02-25 알데릭스, 인코포레이티드 Nhe3-결합 화합물 및 포스페이트 수송을 저해하는 방법
US9765050B2 (en) 2014-12-30 2017-09-19 Novira Therapeutics, Inc. Pyridyl reverse sulfonamides for HBV treatment
CN105395532B (zh) * 2015-11-25 2017-11-14 中国医学科学院医药生物技术研究所 2‑苯磺酰胺基苯甲酰胺类化合物在肝损伤保护和肝纤维化防治中的应用
WO2018043400A1 (ja) * 2016-08-30 2018-03-08 日本曹達株式会社 スルホニルアミノベンズアミド化合物および有害生物防除剤
MA47203A (fr) 2017-01-09 2019-11-13 Ardelyx Inc Inhibiteurs d'antiport à médiation par nhe
MX395405B (es) 2017-01-09 2025-03-25 Ardelyx Inc Compuestos útiles para tratar trastornos del tracto gastrointestinal.
US11390599B2 (en) 2018-06-01 2022-07-19 Promega Corporation Inhibitors of oplophorus luciferase-derived bioluminescent complexes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146513A0 (en) * 1999-06-24 2002-07-25 Smithkline Beecham Corp Macrophage scavenger receptor antagonists
AR030911A1 (es) * 1999-07-20 2003-09-03 Smithkline Beecham Corp Uso de n-aril-2-sulfonamidobenzamidas para la manufactura de un medicamento para el tratamiento de la insuficiencia renal cronica y composiciones farmaceuticas

Also Published As

Publication number Publication date
BR0110034A (pt) 2003-05-27
JP2003533477A (ja) 2003-11-11
CN1429108A (zh) 2003-07-09
WO2001087294A1 (en) 2001-11-22
NO20025399L (no) 2002-11-11
ZA200209106B (en) 2003-10-23
AU2001261471A1 (en) 2001-11-26
CZ20023701A3 (cs) 2003-11-12
IL152587A0 (en) 2003-05-29
CA2408667A1 (en) 2001-11-22
NO20025399D0 (no) 2002-11-11
HUP0302234A2 (hu) 2003-11-28
KR20020093983A (ko) 2002-12-16
MXPA02011160A (es) 2003-03-10

Similar Documents

Publication Publication Date Title
AU2002213048A1 (en) Phosphate transport inhibitors
GB9900416D0 (en) Inhibitors
IL146518A0 (en) Metalloprotease inhibitors
IL147697A0 (en) Phosphate transport inhibitors
PL343435A1 (en) Glycine transport inhibitors
AU3408801A (en) Tnf-alpha inhibitors
IL138227A0 (en) Glycine transport inhibitors
EP1324759A4 (en) NF - G (K) B INHIBITORS
AU2001259354A1 (en) Phosphate transport inhibitors
IL145085A0 (en) Dihetero-substituted metalloprotease inhibitors
IL152587A0 (en) Phosphate transport inhibitors
AU1876002A (en) Transport system
MXPA03000642A (es) Nuevos compuestos y su uso como inhibidores de transportes de glicina.
EP1153022A4 (en) PROTEASE INHIBITORS
GB0030284D0 (en) Enzyme inhibitors
GB0018164D0 (en) Corrosion inhibitors
GB2359500B (en) Corrosion inhibitors
GB2369100B (en) Transport skid
HK1047880A (en) Phosphate transport inhibitors
GB0021193D0 (en) Inhibitors
GB0029733D0 (en) Inhibitors
GB0029730D0 (en) Inhibitors
GB0015996D0 (en) Inhibitors
SI1301502T1 (en) Compounds and their use as glycine transport inhibitors
GB0006009D0 (en) Transport

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)